M32.14 identifies glomerular disease — including lupus nephritis — occurring as a direct manifestation of systemic lupus erythematosus (SLE), classified under SLE with organ or system involvement.

Documentation tips

What should appear in the chart to support M32.14.

Source · Editorial brief grounded in 6 cited references ↓

• Provider must explicitly link the glomerular disease to SLE — a statement such as 'lupus nephritis due to SLE' or 'glomerulonephritis in the setting of systemic lupus erythematosus' satisfies this requirement.
• Record renal biopsy class (ISN/RPS Class I–VI) when available; class-level documentation strengthens medical necessity for nephrology consults, immunosuppressive therapy, and durable renal management plans.
• Document relevant lab findings at each encounter — urinalysis with protein quantification, serum creatinine, BUN, complement levels (C3/C4), and anti-dsDNA titers — to support active disease and justify the specificity of M32.14 over M32.10.
• Clarify whether SLE is active or in remission; payer guidelines and nephrology pre-auth criteria often hinge on disease activity status, and this distinction affects which additional manifestation codes are appropriate.
• If chronic kidney disease is also present, append the appropriate N18.x stage code; ICD-10-CM instructs use of additional codes to identify the full extent of renal impairment.
• Confirm SLE is idiopathic, not drug-induced; if medications (e.g., hydralazine, procainamide) precipitated the SLE, M32.0 replaces M32.14 as the SLE code.

Related CPT procedures

Procedure codes commonly billed with M32.14. Linking the right diagnosis to the right procedure is what establishes medical necessity.

Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis

Common coding pitfalls

The recurring mistakes coders make with M32.14 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

• Using M32.9 (SLE unspecified) when glomerular involvement is documented — this undercodes the encounter and fails specificity requirements; M32.14 is required once renal/glomerular involvement is on record.
• Confusing M32.14 with M32.15: M32.14 is glomerular disease; M32.15 is tubulo-interstitial nephropathy — these are anatomically and clinically distinct and are not interchangeable.
• Failing to append a chronic kidney disease stage code (N18.1–N18.5, N18.6) when CKD is documented alongside lupus nephritis, leaving the severity of renal impairment uncaptured.
• Coding M32.14 based on a history of lupus nephritis without confirming the condition is active or clinically relevant to the current encounter — historical conditions coded in error inflate complexity and can trigger audit flags.
• Applying M32.14 when the provider documents only musculoskeletal symptoms (joint pain, morning stiffness) without evidence of renal/glomerular involvement — joint manifestations alone do not support this code.
• Overlooking secondary diagnosis codes for hypertension, anemia, or infection that are directly related to SLE and its management — incomplete code sets underrepresent disease burden and may affect reimbursement.

Clinical context

Source · Editorial summary grounded in 6 cited references ↓

Inclusion & exclusion notes

Per the official ICD-10-CM Tabular List.

Source · CDC ICD-10-CM Official Tabular List · 2026

Sibling codes

Other billable codes under M32.1 (laterality / anatomic variants).